v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 16,371 $ 13,684
Short-term investments (Note 5) 25,942 30,157
Accounts receivable, net of allowance of $115 and $131 as of March 31, 2025 and December 31, 2024, respectively 10,268 20,608
Prepaid expenses and other current assets 4,823 4,634
Total current assets 57,404 69,083
Property and equipment, net 3,434 4,019
Long-term investments (Note 5) 12,779 8,504
Equity method investment 4,987 5,802
Operating lease right-of-use assets 4,327 3,838
Intangibles, net 2,803 3,024
Goodwill 4,178 4,178
Other assets 8,407 7,687
TOTAL ASSETS 98,319 106,135
Current liabilities:    
Accounts payable 227 539
Accrued expenses and other current liabilities 13,710 15,899
Operating lease liabilities, current 1,047 917
Deferred revenue, current 40,172 40,445
Vendor financing arrangements, current 1,383 1,482
Total current liabilities 56,539 59,282
Deferred revenue, noncurrent 33,552 35,177
Operating lease liabilities, noncurrent 3,495 2,998
Vendor financing arrangements, noncurrent 368 594
Deferred income, noncurrent 7,340 7,631
Other liabilities 1,846 1,641
Total liabilities 103,140 107,323
Commitments and contingencies (Note 10)
Stockholders' deficit:    
Preferred stock, par value of $0.001 - 10,000,000 shares authorized as of both March 31, 2025 and December 31, 2024; no shares issued and outstanding as of both March 31, 2025 and December 31, 2024 0 0
Common stock, par value of $0.001 - 300,000,000 shares authorized as of both March 31, 2025 and December 31, 2024; 41,403,294 and 40,724,936 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 41 40
Additional paid-in capital 140,015 135,522
Accumulated other comprehensive income 129 135
Accumulated deficit (145,006) (136,885)
Total stockholders' deficit (4,821) (1,188)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 98,319 $ 106,135